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Bleeding disorders are a group of conditions that result when the blood cannot clot properly. Hemophilia A and B are perhaps the most well-known inherited bleeding disorder, 
which are X-linked hereditary disorders caused by mutations 
in factor VIII (FVIII) and factor IX (FIX) genes, respectively. 
They are distributed worldwide affecting approximately 1 in 
5000 male births for hemophilia A and 1 in 25,000 male births for 
hemophilia B and often under diagnosed. Many more people are 
affected by Von Willebrand disease, the most common inherited 
bleeding disorder which can affect both males and females. Rare 
clotting factor deficiencies are bleeding disorders in which one of 
the other clotting factors (i.e., factors I, II, V, V + VIII, VII, X, XI, 
or XIII) is missing or not working properly. Less is known about 
these disorders because they are diagnosed so rarely [1-3].
These factors take part in the intrinsic pathway of blood 
coagulation, and affected individuals have severe, moderate, and 
mild forms of the diseases, defined by factor plasma levels of 1% 
or less, 2-5%, and 6-40%, respectively [1-3]. Those with severe 
deficiency (<1% of normal) experience spontaneous bleeding 
without apparent trauma, whereas in moderate deficiency (1-5% of 
normal) there is no spontaneous bleed but may bleed excessively 
after minor trauma, surgery, or other invasive procedures. In mild 
deficiency (5-40% of normal), abnormal bleeding occurs only 
after significant trauma. Females are carriers for hemophilia and 
transmit the disease to their sons, while 30% of the patients have 
no family history and are a result of de novo mutations [4,5].
Although India has a very large population of patients with 
hemophilia and other bleeding disorders, there are very few 
studies on their epidemiology. Based on the 2008 Global Survey 
of the World Federation of hemophilia, nearly 149,000 individuals 
worldwide have hemophilia, hemophilia A being more common. 
15,000-16,000 hemophiliacs are registered with the Hemophilia 
Federation of India [6-9]. Our study is one of the largest cohort 
studies on the epidemiology of bleeding disorders and associated 
from this region. A study leading to the knowledge of spectrum 
of presentation of hemophilia helps in the early diagnosis and 
effective management.
MATERIAL AND METHODS
This observational study was conducted on all children <18 years 
of age with bleeding disorders attending Comprehensive 
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Hemophilia Center from December 2015 to August 2016. It is 
also the Nodal Center for Hemophilia Care in Karnataka at 
Bangalore Medical College and Research Institute. Informed 
written consent was obtained for the use of patient information for 
research and studies. Patients with platelet and vascular disorders 
and those older than 18 years were excluded from the study. 
Detailed clinical history and a thorough clinical examination 
were performed on these patients. The questionnaire included 
details of past treatment and bleeding episodes, family history 
and pedigree analysis, mode of presentation, age of onset of the 
disease, associated symptoms, and drug history.
The blood sample was collected and subjected to fresh complete 
coagulation workup on all patients, which included complete 
blood count using automated hematology analyzer, bleeding 
time (modified Ivy’s method), clot retraction time, platelet count, 
and platelet morphology. Hematological parameters obtained by 
5 Part Beckman LH 780 analyzer for hemoglobin, hematocrit, 
white blood cells count (total leukocyte count), differential count, 
platelet count, blood grouping by slide method, and peripheral 
smear examination were done. These tests were followed by 
tests for prothrombin time, activated partial thromboplastin time 
(APTT), and thrombin time by Sysmex CA-620 coagulometer. 
Correction test was done using adsorbed plasma, aged serum, 
Factor VIII deficient plasma, Factor IX deficient plasma, and 
normal pooled plasma to know the factor deficiency followed 
by respective factor assay. Tests to identify inhibitors (Inhibitor 
screening and assay) were done as required as per established 
protocols.
A separate questionnaire was given and discussed with patients 
for ascertaining details pertaining to the social and psychological 
impact from their disease. A dysfunctional family was defined as 
one in which conflict, misbehavior, and often child neglect or abuse 
on the part of individual parents occur continually and regularly, 
leading other members to accommodate such actions. Children 
sometimes grow up in such families with the understanding that 
such an arrangement is normal [10]. Statistics were analyzed 
using Microsoft Excel sheet and presented as percentages.
RESULTS
Among the 126 cases of bleeding disorders, 123 (97.6%) were 
male and 3 (2.4 %) were female. Mean age at diagnosis was 
2.5±2.55 years (range-1 month to 8 years), and there was a time lag 
between the first bleeding and diagnosis of 27 days. The APTT was 
prolonged in all the cases. The family history of hemophilia was 
seen in 45.2% (57/126) of cases. Of the 3 female patients, 2 had Von 
Willebrand disease and 1 had factor 5 deficiency. 101 (80.2%) cases 
had hemophilia A, and 15 (11.9%) cases had hemophilia B. A total of 
3 (2.4%) cases had Von Willebrand disease. Other rare deficiencies 
7 (5.5%) included 2 each with factor XIII deficiency and congenital 
fibrinogen deficiency and 1 each with factor X deficiency, factor VII 
deficiency, and Factor V deficiency, respectively.
Among the hemophilia A, 4 (4%) cases had mild, 23 (22.8%) 
had moderate, and 74 (73.2%) had severe hemophilia, and among 
the hemophilia B, 3 (20%) cases had moderate, and 12 (80%) 
cases had severe disease. 24 (19%) children were between 0 and 
5 years, 29 (23%) were between 5 and 10 years, the majority 
56 (44.4%) were 10-15 years old, and 17 (13.4%) were from 
15 to 18 years of age. 34% of cases had initial bleeding episode 
before 1 year of age and by 5 years of age, and 80% of the cases 
were symptomatic. None of the children was diagnosed with 
bleeds during neonatal period. Inhibitors were seen in 9 (7.14%) 
of children with hemophilia A, with 6 (66.7%) having high-titer 
inhibitors and 3 (33.3%) had low-titer inhibitors. Only one child 
was positive for hepatitis C virus (HCV) infection, and none of 
them had human immunodeficiency virus (HIV) infection or 
hepatitis B infection.
There were totally 285 bleeding episodes in 126 patients. 
Joint bleeding (52.9%) either spontaneous or after trauma was 
the main forms of bleeds (Table 1), followed by bruises and 
skin hematomas, oral cavity bleeding, and muscle bleeds with 
majority being psoas muscle bleeds. Among the joint bleeds, 
the knee was the most commonly affected, followed by elbow, 
ankle, hip, metatarsophalangeal joints, and wrist and shoulder 
joints, respectively (Table 2). Among the major and life-
threatening bleeds, intracranial bleeds were seen in 5 (16.7%) 
cases, hematemesis and melena in 7 (23.3%), liver hematoma in 
1 (3.3%), forearm muscle bleed with compartment syndrome in 
2 (6.7%), ophthalmic bleeds in 2 (6.7%), and severe epistaxis in 
3 (10%) cases. Psoas muscle bleeds in 10 (33.3%) followed by 
hematemesis and melena in 7 (23.3%) were the most common 
Table 1: Type of bleeds
Type of bleeds Number (%)
Joint 151 (52.9)
Bruises and skin hematomas 45 (15.8)
Gum/oral 29 (10.2)
Hematuria 1 (0.35)
Epistaxis 14 (4.91)
Post-Circumcision 4 (1.40)
Muscle bleed 26 (9.12)
Intracranial bleed 5 (1.75)
GI (Hematemesis±melena) 7 (2.46)
Liver hematoma 1 (0.35)
Ophthalmic bleeds 2 (0.76)
Total 285 (100)
Table 2: Frequency of the joints involved
Joint affected Number of bleeds (%)
Knee 53 (35)
Ankle 34 (22.5)
Elbow 40 (26.5)
Shoulder 3 (2)
Wrist 5 (3.6)
Toe 6 (4)
Hip 10 (6.6)
Total 151 (100)
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critical bleed seen in our patients. 30% of those with hematemesis 
gave a history of over the counter non-steroidal anti-inflammatory 
drugs intake. Psoas muscle bleed and epistaxis were seen in 
patients of both hemophilia B and A, whereas other critical 
bleeds such as liver bleed and intracranial bleed were seen only in 
children with severe hemophilia A.
Children with hemophilia commonly face a number of 
psychosocial challenges. We observed school absenteeism in 
86 (68.25%) cases, and an average of 5 days of schooling per 
month was missed. Family dysfunction was rampant with 
64 (50.8%) affected cases. Parental separation was seen in 
27 (21.4%) and parental divorce in 3 (2.4%) cases. Mothers 
were blamed for the disease and victimized in 10 (7.9%) cases. 
An interesting observation was mothers deserting the child and 
family in 2 families, one mother having left the family and another 
committed suicide without any pressure from the marital family.
DISCUSSION
Both hemophilia A and B are indistinguishable clinically from 
each other. The diagnosis of hemophilia is based on factor assays, 
bleeding patterns, and family history; although, about 30% of 
those diagnosed do not have a family history of the disorder 
and are a result of de novo mutations [5]. The mainstay of 
treatment is replacement of the deficient factor. The two main 
concerns with factor replacement are transmission of pathogenic 
viruses or prions and the development of inhibitors. One of the 
most important complications of hemophilia treatment is the 
development of antibodies or inhibitors, to the exogenous factor, 
inactivating the infused coagulation factor. Inhibitor development 
is much more common in hemophilia A than in hemophilia B 
and is reported in up to 38% of patients with hemophilia A [7-9]. 
Inhibitors were seen in 9 (7.14%) of the children with hemophilia 
A in our study. No patient of hemophilia B had inhibitors in our 
series. Perhaps, more vigilant screening and prolonged follow-up 
is needed to detect inhibitors.
Demographic profile of patients was similar to other 
studies [12-21], with severe hemophilia A being the most 
common, similar to the findings by Mishra et al. [14] and Sharma 
and Arya [15]. Some studies may show higher incidence of mild 
hemophilia as severe and moderate cases of hemophilia get 
misdiagnosed as mild hemophilia if tested after blood or blood 
product transfusion. There was no symptomatic patient with mild 
hemophilia B in our study. There was a mean time lag between 
first bleeding and diagnosis of 27 days, which shows a lack of 
awareness among doctors in the community.
Joint bleeds have been reported as the most common site of 
spontaneous bleeding [12-15]. Even in our series, joint bleeding 
was the main forms of bleeds with hemarthrosis of knee joint 
being the most common type, which is similar to the results of 
other studies by Sharma and Arya [15] and Parthiban et al. [13]. 
Psoas muscle bleeds followed by hematemesis and melena was 
the most common critical bleed seen in our patients. Major 
life-threatening bleeds were seen only in children with severe 
deficiency of the respective coagulation factor. Bleeds such as 
intracranial bleed and liver bleeds were seen only in patients with 
severe hemophilia A in our study.
Only one child was HCV positive and none of them had HIV 
or hepatitis B infection. Incidence of transfusion-transmitted 
infections in the pediatric age group (i.e., <18 years) who were 
born in the late 90s and 2000AD onward when safer factor 
concentrates were available and strict transfusion practices were 
followed was very low, as reported in literature [22-24]. The 
introduction of virus inactivated plasma-derived coagulation 
factors and then of recombinant products has revolutionized 
hemophilia care. The development and implementation of viral 
inactivation techniques for the production of plasma-derived 
factor concentrates, as well as the adoption of new methods to 
screen viruses in blood donation (i.e., nucleic acid testing), 
greatly improved the safety of plasma-derived products, as shown 
by the fact that blood-borne transmission of hepatitis viruses or 
HIV has no longer occurred in the past 25 years. However, the 
most important advance in this field was represented by the rapid 
progress in DNA technology (following the cloning in 1982 and 
1984 of FVIII and FIX genes), which allowed the industrial 
production of recombinant FVIII (and subsequently of FIX), 
culminating with the use of recombinant factor products [22-24].
We observed a number of psychosocial challenges in our 
hemophiliacs such as school absenteeism, family dysfunction, 
depression, and low self-esteem. Parental separation and divorce 
were seen quite often. Thus, to provide optimal care, health-care 
professionals need to be able to identify issues and challenges 
related to having a bleeding disorder that may be affecting their 
patients’ cognitive and emotional development. A bleeding 
disorder is a chronic condition that imposes limitations, but it 
can also represent an opportunity to bring about positive change 
through learning and self-awareness. There are different ways 
of experiencing and coping with pain and chronic illness. Some 
people with hemophilia may focus on the emotional challenges, 
while others find ways to better cope with their situation. Mothers 
of hemophiliacs face special challenges. Apart from the guilt 
feelings associated with the birth of a child with hemophilia, 
women who have a family history of hemophilia suffer torture in 
tradition-bound households at the hands of husband, relatives, and 
society. Greater is the misery when she is abandoned by husband 
as she is tainted, incapable of bearing normal children. She may 
seek refuge in her parents who may or may not be in a position to 
help. Moreover, bringing up the child with hemophilia all alone 
itself takes a heavy toll on her physical and mental health [10,11].
Short-term psychotherapy and psychosocial services can 
help individuals with hemophilia cope with symptoms and 
limitations and develop a healthy sense of self. Studies and 
data on psychosocial aspects of the hemophilia are lacking in 
the published literature, especially from developing countries. 
There is a need for more international, multifaceted research to 
explore and quantify the social and psychological aspects of life 
with hemophilia. Interventions by the multidisciplinary team to 
support the psychosocial needs of patients and their families, such 
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as offering information and assistance, clarifying doubts, and 
teaching coping strategies to minimize the impact of disabilities, 
may help to maximize patient outcomes and improve the quality 
of life for their families. The goals of intervention should be to 
maintain good physical function, prevent joint disease and chronic 
pain, and screen patients for early signs of mental health problems 
that can negatively impact the quality of life and adherence to 
treatment.
CONCLUSIONS
In our study, the majority had hemophilia A and were males. Joint 
bleeding was the most common bleed with hemarthrosis of knee 
joint being the major presentation. Psoas muscle bleeds were the 
most common critical bleed. Major life-threatening bleeds such 
as intracranial bleed and liver bleeds were seen only in patients 
with severe hemophilia A in our series. Incidence of transfusion-
transmitted infections in the pediatric age group was very low. 
Psychosocial support is an important part of comprehensive care 
for people with hemophilia.
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